Trials / Completed
CompletedNCT04539652
Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients
A Multicenter, Single-Arm, Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients in Treatment of Oral Antiviral Therapy for Hepatitis B Virus
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to evaluate the rate of subjects with HBV DNA less than 20 IU/mL after taking TenofoBell® tablet for 48 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Experimental | Experimental group are treated with TenofoBell® |
Timeline
- Start date
- 2018-09-20
- Primary completion
- 2021-06-22
- Completion
- 2021-06-22
- First posted
- 2020-09-07
- Last updated
- 2021-07-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04539652. Inclusion in this directory is not an endorsement.